Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Find out which cash back credit cards have no annual fee to suit your spending habits. Discover the perfect card for you today!
27,937 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Goldman Sachs and KeyBanc boosted AT&T price targets after the telecom giant unveiled a three-segment reporting model...
Nvidia stock sank today as investors weighed growth, margins, and AI demand ahead of next week’s earnings. This guide...
Midyear market shifts put Buffett's moat concept under stress as MOAT slips while the broad market climbs. Here’s wha...
Apple stock is trading in the high 300s as traders weigh a possible rally. Here are three catalysts that could push a...
Market mood slides while retail spend stays resilient. Three beaten-down consumer stocks july look poised for catalys...
IBM is attracting fresh investor attention as its AI infrastructure strategy gains traction. Arvind Krishna’s reshape...
Shares moved lower after Netflix issued a softer-than-expected Q3 outlook, prompting a wave of questions about growth...
Three growth-focused ETFs have fallen this month as rates move and leadership shifts unsettle risk assets. One fund s...
A seemingly small line in Nvidia's latest earnings release hints at a larger shift toward edge computing. For investo...
AI chips run hot, and the race to cool them efficiently is reshaping data centers and stock stories. This article exp...
A multi-jurisdictional probe led to indictments for 62 people connected to a massive crypto-laundering operation. The...